ATE188697T1 - Substituierte phenylcarbamate und phenylharnstoffe, ihre herstellung und ihre verwendung als 5-ht4-antagonisten - Google Patents

Substituierte phenylcarbamate und phenylharnstoffe, ihre herstellung und ihre verwendung als 5-ht4-antagonisten

Info

Publication number
ATE188697T1
ATE188697T1 AT93908861T AT93908861T ATE188697T1 AT E188697 T1 ATE188697 T1 AT E188697T1 AT 93908861 T AT93908861 T AT 93908861T AT 93908861 T AT93908861 T AT 93908861T AT E188697 T1 ATE188697 T1 AT E188697T1
Authority
AT
Austria
Prior art keywords
preparation
substituted
antagonists
ureas
phenylcarbamates
Prior art date
Application number
AT93908861T
Other languages
English (en)
Inventor
Alexander William Oxford
Limited
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929206989A external-priority patent/GB9206989D0/en
Priority claimed from GB929217827A external-priority patent/GB9217827D0/en
Priority claimed from GB929221718A external-priority patent/GB9221718D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ATE188697T1 publication Critical patent/ATE188697T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
AT93908861T 1992-03-31 1993-03-26 Substituierte phenylcarbamate und phenylharnstoffe, ihre herstellung und ihre verwendung als 5-ht4-antagonisten ATE188697T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB929206989A GB9206989D0 (en) 1992-03-31 1992-03-31 Chemical compounds
GB929217827A GB9217827D0 (en) 1992-08-21 1992-08-21 Chemical compounds
GB929221718A GB9221718D0 (en) 1992-10-16 1992-10-16 Chemical compounds
PCT/EP1993/000779 WO1993020071A1 (en) 1992-03-31 1993-03-26 Substituted phenylcarbamates and phenylureas, their preparation and their use as 5-ht antagonists

Publications (1)

Publication Number Publication Date
ATE188697T1 true ATE188697T1 (de) 2000-01-15

Family

ID=27266122

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93908861T ATE188697T1 (de) 1992-03-31 1993-03-26 Substituierte phenylcarbamate und phenylharnstoffe, ihre herstellung und ihre verwendung als 5-ht4-antagonisten

Country Status (17)

Country Link
EP (2) EP0640081B1 (de)
JP (1) JP3236298B2 (de)
AT (1) ATE188697T1 (de)
AU (1) AU663780B2 (de)
CA (1) CA2133083A1 (de)
CZ (1) CZ236894A3 (de)
DE (1) DE69327583T2 (de)
DK (1) DK0640081T3 (de)
ES (1) ES2141763T3 (de)
FI (1) FI944513A7 (de)
GR (1) GR3032877T3 (de)
HU (1) HUT72321A (de)
NO (1) NO943631L (de)
NZ (1) NZ251687A (de)
PT (1) PT640081E (de)
SK (1) SK116394A3 (de)
WO (1) WO1993020071A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR970701174A (ko) * 1994-02-10 1997-03-17 오노다 마사요시 신규한 카바메이트 유도체 및 이의 의약 조성물(Novel carbamate derivative and medicinal composition containing the same)
FR2750991A1 (fr) * 1996-07-12 1998-01-16 Pf Medicament Nouveaux benzodioxannes et 1-(2h)-benzopyrannes, leur preparation et leur utilisation comme medicament
FR2752732B1 (fr) 1996-08-28 1998-11-20 Pf Medicament Forme galenique a liberation prolongee de milnacipran
US6693202B1 (en) 1999-02-16 2004-02-17 Theravance, Inc. Muscarinic receptor antagonists
AU783095B2 (en) * 1999-12-07 2005-09-22 Theravance Biopharma R&D Ip, Llc Carbamate derivatives having muscarinic receptor antagonist activity
UA73543C2 (uk) * 1999-12-07 2005-08-15 Тераванс, Інк. Похідні сечовини, фармацевтична композиція та застосування похідного при приготуванні лікарського засобу для лікування захворювання, яке опосередковується мускариновим рецептором
CN100413539C (zh) * 2000-08-07 2008-08-27 葛兰素史密斯克莱实验室公司 5-ht4受体拮抗剂在制备治疗电生理心房改型的药物中的应用
WO2002018335A1 (en) * 2000-08-28 2002-03-07 Yamanouchi Pharmaceutical Co., Ltd. Cyclic amine derivatives
FR2821356A1 (fr) * 2001-02-23 2002-08-30 Cerep Nouveaux derives d'arylcarbamates et d'arylurees, preparations et utilisations
FR2843750B1 (fr) * 2002-08-23 2004-10-22 Cerep Composes derives d'arylcarbamates, preparation et utilisations
PE20040950A1 (es) 2003-02-14 2005-01-01 Theravance Inc DERIVADOS DE BIFENILO COMO AGONISTAS DE LOS RECEPTORES ADRENERGICOS ß2 Y COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS
US7345060B2 (en) 2003-11-21 2008-03-18 Theravance, Inc. Compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity
EP1833822A2 (de) 2004-08-16 2007-09-19 Theravance, Inc. Verbindungen mit beta2 adrenerg-rezeptor agonistischer und muscarin-rezeptor antagonistischer aktivität
EP1778626A1 (de) 2004-08-16 2007-05-02 Theravance, Inc. Zusammensetzungen mit beta2-adrenergen-rezeptoragonist- und muskarinrezeptorantagonist-aktivität
GB0602778D0 (en) 2006-02-10 2006-03-22 Glaxo Group Ltd Novel compound

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA76475B (en) * 1975-03-10 1977-08-31 Ciba Geigy Ag Indolyalkylpiperidines
JPH0140026B2 (de) * 1978-07-03 1989-08-24 Amerikan Hoomu Purodakutsu Corp
IE63474B1 (en) * 1987-12-24 1995-04-19 Wyeth John & Brother Ltd Heterocyclic compounds
DK443489D0 (da) * 1989-09-08 1989-09-08 Ferrosan As Substituerede urinstofforbindelser, deres fremstilling og anvendelse
FR2677019B1 (fr) * 1991-05-27 1994-11-25 Pf Medicament Nouvelles piperidines disubstituees-1,4, leur preparation et leur application en therapeutique.
FR2679555B1 (fr) * 1991-07-25 1993-11-19 Fabre Medicament Pierre Nouveaux derives de l'uree, leur preparation et leur application en therapeutique.

Also Published As

Publication number Publication date
AU663780B2 (en) 1995-10-19
JP3236298B2 (ja) 2001-12-10
PT640081E (pt) 2000-05-31
SK116394A3 (en) 1995-04-12
FI944513A0 (fi) 1994-09-29
EP0640081A1 (de) 1995-03-01
CA2133083A1 (en) 1993-10-14
EP0640081B1 (de) 2000-01-12
DE69327583T2 (de) 2000-05-31
NO943631L (no) 1994-11-29
AU3949793A (en) 1993-11-08
WO1993020071A1 (en) 1993-10-14
FI944513A7 (fi) 1994-11-29
JPH07505868A (ja) 1995-06-29
DE69327583D1 (de) 2000-02-17
HU9402825D0 (en) 1994-12-28
HUT72321A (en) 1996-04-29
CZ236894A3 (en) 1995-09-13
ES2141763T3 (es) 2000-04-01
DK0640081T3 (da) 2000-06-19
NO943631D0 (no) 1994-09-29
NZ251687A (en) 1995-12-21
EP0972773A1 (de) 2000-01-19
GR3032877T3 (en) 2000-07-31

Similar Documents

Publication Publication Date Title
ATE188697T1 (de) Substituierte phenylcarbamate und phenylharnstoffe, ihre herstellung und ihre verwendung als 5-ht4-antagonisten
NO953305D0 (no) Antranilsyrederivat
ATE176912T1 (de) 2-piperazinon-verbindungen und deren verwendung
DK0568306T3 (da) Anitkonvulsive fructopyranose cycliske sulfitter og sulfater
ES2070660B1 (es) Un procedimiento para la preparacion de 2,5-damino-3-hidroxihexanos sustituidos, utiles como inhibidores de proteasas retrovirales.
FI924454A0 (fi) Nya 7-substituerad-9-(substituerad amino)-6-demetyl-6-deoxitetracykliner
DE69615802D1 (de) Heterocyclische substituierte Benzofuran-Harnstoffe
EP0291917A3 (en) Novel oxetanocins
ES8105274A1 (es) Un procedimiento para la preparacion de derivados de acido benceno -1,2,-disulfonico.
PH18858A (en) Herbicidally active novel substituted phenyl-sulfonylurea derivatives and intermediates therefor
DE69202120D1 (de) Harnstoffderivate, ihre Herstellung und ihre Verwendung bei der Therapie.
DE69028610D1 (de) Chirale 1,5-diiodo-2-methoxy oder benzyloxy Zwischenprodukte
ES8402566A1 (es) Procedimiento para preparar fenilsulfonilisocianatos sustituidos.
IL71361A0 (en) Urea derivatives,their preparation and their use as pesticides
ES2158290T3 (es) Derivados de tiazolidinona opticamente activos.
SE8501988D0 (sv) Iminothiazolidine derivatives
DE68907925D1 (de) Oxadiazolverbindungen, ihre herstellung und ihre verwendung als pestizide.
IT1241988B (it) 2- amminotetraline-6, 7-sostituite attive come immunomodulanti e composizioni farmaceutiche che le contengono
ATE45732T1 (de) Carboxamid-derivate, ihre herstellung und ihre verwendung als fungizidmittel.
ATE142201T1 (de) 2- und 3-amino und azidoderivate von 1,5- iminozuckern als antivirale arzneimittel
DE69303352D1 (de) Verfahren zur Herstellung 5-Pyrazolomerkaptan-Derivate und dessen zwischenprodukte
DK305182A (da) Biologisk aktive heterobicycliske hydroximidater og thiolhydroximidater samt carbamatesterderivater deraf

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee